Ensuring people in Australia have the best access to care and treatment is a high priority for Hepatitis Australia. The involvement of primary and tertiary doctors and nurses is vital.

To support this, Australia has several guiding documents for the diagnosis, monitoring and treatment of both hepatitis B and hepatitis C. Please use the green links below to access the documents.

National Hepatitis Testing Policies

Australia has clear policies to inform testing procedures for both hepatitis B and hepatitis C. Health professionals are encouraged to understand and implement the following policies.

National Hepatitis B Testing Policy

National Hepatitis C Testing Policy

Hepatitis C Treatment Guidelines

Leading national clinical bodies experienced in hepatitis along with Hepatitis Australia have informed the Australian recommendations for the management of hepatitis C infection. 

Decision making in Hepatitis C

HCV In Children: Australian Commentary On AASLD-IDSA Guidance

Decision Making – Hepatitis C In Children

B Positive: Hepatitis B for Primary Care

Produced by ASHM, B Positive is a guide for primary care providers. This guide provides a comprehensive summary of currently available knowledge and practice.

B Positive Guide

Hepatitis B and Hepatitis C in Antenatal Care

This resource is for primary health care professionals providing antenatal care including nurses, midwives, general practitioners and Aboriginal and Torres Strait Islander Health Workers and Practitioners.

It contains advice about recommended antenatal testing for hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV) and syphilis. In addition, it provides information about the management of these BBVs and STIs during pregnancy, labour and birth, and the postpartum period.

Bloodborne Viruses and Sexually Transmissible Infections in Antenatal Care

Hepatocellular Carcinoma (HCC) Surveillance

The Clinical practice guidelines for HCC surveillance for people at high risk in Australia aim to provide information and recommendations to guide surveillance for people at high risk of HCC. Evidence has shown it to be successful in detecting lesions and/or early-stage tumours, increasing the receipt of curative treatment and improving overall survival.

The development of these Guidelines was led by eminent clinicians in the area of liver disease and liver cancer, Co-Chairs Professor Jacob George and Dr Nicole Allard, alongside a multi-disciplinary working party, including healthcare and clinical representatives, representatives with lived experience and other community representatives. 

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia

More information about viral hepatitis for clinicians

Hepatitis Australia recommends that doctors or nurses interested in hepatitis B or C access the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) for further information.

ASHM - Hepatitis B Training, Information and Resources

ASHM - Hepatitis C Training, Information and Resources

Page updated: 26 October 2022